These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14962950

  • 1. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 2. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 3. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
    Boyanovsky BB, van der Westhuyzen DR, Webb NR.
    J Biol Chem; 2005 Sep 23; 280(38):32746-52. PubMed ID: 16040605
    [Abstract] [Full Text] [Related]

  • 4. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau L, Lazdunsky M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2005 Sep 05; 1736(1):38-50. PubMed ID: 16122976
    [Abstract] [Full Text] [Related]

  • 5. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May 05; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 6. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
    Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.
    Arterioscler Thromb Vasc Biol; 2007 Mar 05; 27(3):600-6. PubMed ID: 17204667
    [Abstract] [Full Text] [Related]

  • 7. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
    Rosengren B, Peilot H, Umaerus M, Jönsson-Rylander AC, Mattsson-Hultén L, Hallberg C, Cronet P, Rodriguez-Lee M, Hurt-Camejo E.
    Arterioscler Thromb Vasc Biol; 2006 Jul 05; 26(7):1579-85. PubMed ID: 16601231
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C, Gustafsson M, Pitas RE, Arnaboldi L, Walzem RL, Borén J.
    Arterioscler Thromb Vasc Biol; 2004 Mar 05; 24(3):564-70. PubMed ID: 14726411
    [Abstract] [Full Text] [Related]

  • 9. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M, Kudo I.
    Curr Opin Lipidol; 2003 Oct 05; 14(5):431-6. PubMed ID: 14501581
    [Abstract] [Full Text] [Related]

  • 10. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y, Saiga A, Yokota Y, Suzuki N, Ikeda M, Ono T, Nakano K, Fujii N, Ishizaki J, Arita H, Hanasaki K.
    Arch Biochem Biophys; 2000 Sep 01; 381(1):31-42. PubMed ID: 11019817
    [Abstract] [Full Text] [Related]

  • 11. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA, Samoilova EV, Kaminny AI, Pirkova AA, Resink TJ, Erne P, Prokazova NV, Tkachuk VA, Chazov EI.
    Mol Cell Biochem; 2005 Feb 01; 270(1-2):107-13. PubMed ID: 15792359
    [Abstract] [Full Text] [Related]

  • 12. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ.
    Arterioscler Thromb Vasc Biol; 2013 Dec 01; 33(12):2707-14. PubMed ID: 24115030
    [Abstract] [Full Text] [Related]

  • 13. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
    Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP.
    J Lipid Res; 2005 Feb 01; 46(2):201-10. PubMed ID: 15576846
    [Abstract] [Full Text] [Related]

  • 14. Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins.
    Neuzil J, Upston JM, Witting PK, Scott KF, Stocker R.
    Biochemistry; 1998 Jun 23; 37(25):9203-10. PubMed ID: 9636068
    [Abstract] [Full Text] [Related]

  • 15. Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.
    Kamitani S, Yamada K, Yamamoto S, Ishimoto Y, Ono T, Saiga A, Hanasaki K.
    Cell Mol Biol Lett; 2012 Sep 23; 17(3):459-78. PubMed ID: 22706677
    [Abstract] [Full Text] [Related]

  • 16. Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis.
    Balestrieri B, Hsu VW, Gilbert H, Leslie CC, Han WK, Bonventre JV, Arm JP.
    J Biol Chem; 2006 Mar 10; 281(10):6691-8. PubMed ID: 16407308
    [Abstract] [Full Text] [Related]

  • 17. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ, Pratico D, Ding T, Funk CD, Hildebrand RB, Van Berkel T, Van Eck M.
    J Lipid Res; 2005 Aug 10; 46(8):1604-14. PubMed ID: 15897607
    [Abstract] [Full Text] [Related]

  • 18. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
    Pruzanski W, Kopilov J, Kuksis A.
    Prostaglandins Other Lipid Mediat; 2016 Jan 10; 122():64-8. PubMed ID: 26711221
    [Abstract] [Full Text] [Related]

  • 19. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
    Blache D, Gautier T, Tietge UJ, Lagrost L.
    FASEB J; 2012 Feb 10; 26(2):927-37. PubMed ID: 22042222
    [Abstract] [Full Text] [Related]

  • 20. Expression and induction of secretory phospholipase A2 group IB in brain.
    Kolko M, Christoffersen NR, Varoqui H, Bazan NG.
    Cell Mol Neurobiol; 2005 Nov 10; 25(7):1107-22. PubMed ID: 16392040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.